I graduated from the University of Belgrade in 1990 with a B.Sc. degree in Molecular Biology and Physiology. Following the civil war in former Yugoslavia I left in 1993 for Philadelphia, USA, where in 1998 I obtained my PhD in Molecular and Cell Biology Program from the MCP-Hahnemann University (now a part of Drexel University). My PhD project was focused on cancer biology, in particular p53-MDM2 pathway, and during my PhD studies I identified two novel MDM2 binding proteins: DNA polymerase epsilon and MTBP. My first post-doctoral position was at the University of Pennsylvania in Philadelphia where I spent a year working on childhood rhabdomyosarcoma project. In 1999 I came to the University of Liverpool, where I worked as a Research associate and together with Prof. Mark Boyd established the p53-MDM2 research group. I obtained my first Lecturing post in 2002 and since then I have been running the p53-MDM2 research group together with Prof. Mark Boyd. I was promoted into a Senior Lecturer in 2013 and since 2015 I am a Director for PGR Studies for the Department of Molecular and Clinical Cancer Medicine.